N/A
Completed N=93
Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes
Source: ClinicalTrials.gov NCT04704193 ↗Enrolled (actual)
93
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Participant Satisfaction With How Educational Information is Presented in the Decision Aid — 1; 3; 29; 55 Participants
Summary
An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion of the decision aid, participants will be asked to indicate their decision about whether to pursue genetic testing and which specific multi-gene panel to pursue. A survey will then be administered to assess participants' opinions on the decision aid.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participant Satisfaction With How Educational Information is Presented in the Decision Aid |
1; 3; 29; 55; 2; 4 | — |
| SECONDARY Total Time Spent on Decision Aid |
13.7 | — |
Eligibility Criteria
Inclusion Criteria
- Adults (18 years of age or older)
- Diagnosed with malignant ovarian tumor or malignant pancreatic adenocarcinoma
Exclusion Criteria
- Children (<18 years of age)
- Unable to complete surveys
- Previous germline genetic testing
Data sourced from ClinicalTrials.gov (NCT04704193). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.